Apollo Hospitals Enterprise 미래 성장

Future 기준 확인 5/6

Apollo Hospitals Enterprise (는) 각각 연간 30.7% 및 17.2% 수익과 수익이 증가할 것으로 예상됩니다. EPS는 연간 30.4% 만큼 성장할 것으로 예상됩니다. 자기자본이익률은 3년 후 21.7% 로 예상됩니다.

주요 정보

30.7%

수익 성장률

30.4%

EPS 성장률

Healthcare 수익 성장	27.6%
매출 성장률	17.2%
향후 자기자본 수익률	21.7%
애널리스트 커버리지	Good
마지막 업데이트	06 Dec 2024

최근 미래 성장 업데이트

Here's What Analysts Are Forecasting For Apollo Hospitals Enterprise Limited (NSE:APOLLOHOSP) After Its Second-Quarter Results

Nov 09

The Apollo Hospitals Enterprise Limited (NSE:APOLLOHOSP) First-Quarter Results Are Out And Analysts Have Published New Forecasts

Aug 16

Analysts Are Updating Their Apollo Hospitals Enterprise Limited (NSE:APOLLOHOSP) Estimates After Its Third-Quarter Results

Feb 11

Recent updates

Is Apollo Hospitals Enterprise (NSE:APOLLOHOSP) A Risky Investment?

Dec 10

Here's What Analysts Are Forecasting For Apollo Hospitals Enterprise Limited (NSE:APOLLOHOSP) After Its Second-Quarter Results

Nov 09

Why We Think Apollo Hospitals Enterprise Limited's (NSE:APOLLOHOSP) CEO Compensation Is Not Excessive At All

Aug 24

The Apollo Hospitals Enterprise Limited (NSE:APOLLOHOSP) First-Quarter Results Are Out And Analysts Have Published New Forecasts

Aug 16

Apollo Hospitals Enterprise's (NSE:APOLLOHOSP) Upcoming Dividend Will Be Larger Than Last Year's

Aug 06

Apollo Hospitals Enterprise (NSE:APOLLOHOSP) Is Increasing Its Dividend To ₹10.00

Jul 23

Apollo Hospitals Enterprise's (NSE:APOLLOHOSP) Returns On Capital Are Heading Higher

Apr 08

These 4 Measures Indicate That Apollo Hospitals Enterprise (NSE:APOLLOHOSP) Is Using Debt Reasonably Well

Mar 18

Analysts Are Updating Their Apollo Hospitals Enterprise Limited (NSE:APOLLOHOSP) Estimates After Its Third-Quarter Results

Feb 11

Apollo Hospitals Enterprise Limited's (NSE:APOLLOHOSP) Share Price Not Quite Adding Up

Jan 25

수익 및 매출 성장 예측

NSEI:APOLLOHOSP - 애널리스트의 미래 추정치 및 과거 재무 데이터 (INR Millions )
날짜	수익	수익	잉여 현금 흐름	작전 현금	평균 애널리스트 수
3/31/2027	312,009	25,746	22,839	34,923	24
3/31/2026	263,869	19,738	16,849	29,074	29
3/31/2025	221,137	14,544	12,505	22,067	28
9/30/2024	204,694	11,876	5,096	16,464	N/A
6/30/2024	197,270	10,372	N/A	N/A	N/A
3/31/2024	190,592	8,986	7,834	19,202	N/A
12/31/2023	184,175	7,893	N/A	N/A	N/A
9/30/2023	178,305	6,975	2,151	13,436	N/A
6/30/2023	172,347	6,685	N/A	N/A	N/A
3/31/2023	166,125	8,191	2,484	13,769	N/A
12/31/2022	158,566	7,647	N/A	N/A	N/A
9/30/2022	152,320	8,396	14,813	21,385	N/A
6/30/2022	146,980	8,834	N/A	N/A	N/A
3/31/2022	146,626	10,556	10,388	16,960	N/A
12/31/2021	139,841	11,334	N/A	N/A	N/A
9/30/2021	131,051	10,354	11,963	14,918	N/A
6/30/2021	121,487	8,479	N/A	N/A	N/A
3/31/2021	105,600	1,504	9,692	12,647	N/A
12/31/2020	106,145	2,018	N/A	N/A	N/A
9/30/2020	107,664	1,635	6,816	11,946	N/A
6/30/2020	108,464	1,895	N/A	N/A	N/A
3/31/2020	112,468	4,549	7,799	12,929	N/A
12/31/2019	108,239	3,172	N/A	N/A	N/A
9/30/2019	104,072	2,821	1,812	8,601	N/A
6/30/2019	99,789	2,593	N/A	N/A	N/A
3/31/2019	96,175	2,360	2,263	9,052	N/A
3/31/2018	82,435	1,174	N/A	5,370	N/A
3/31/2017	72,557	2,210	N/A	6,226	N/A
3/31/2016	62,147	2,364	N/A	5,972	N/A
3/31/2015	51,785	3,399	N/A	4,699	N/A
3/31/2014	43,842	3,167	N/A	3,734	N/A

애널리스트 미래 성장 예측

수입 대 저축률: APOLLOHOSP 의 연간 예상 수익 증가율( 30.7% )이 saving rate( 6.7% 보다 높습니다. ).

수익 vs 시장: APOLLOHOSP 의 연간 수익( 30.7% ) Indian 시장( 18.1% 보다 빠르게 성장할 것으로 예상됩니다. 18.1% 연간).

고성장 수익: APOLLOHOSP 의 수입은 향후 3년 동안 상당히 증가할 것으로 예상됩니다.

수익 대 시장: APOLLOHOSP 의 수익(연간 17.2% ) Indian 시장( 10.5% 보다 빠르게 성장할 것으로 예상됩니다. 10.5% 연간).

고성장 수익: APOLLOHOSP 의 수익(연간 17.2% )은 연간 20% 보다 느리게 증가할 것으로 예상됩니다.

주당 순이익 성장 예측

미래 자기자본 수익률

미래 ROE: APOLLOHOSP 의 자본 수익률은 3년 내에 최고 수준이 될 것으로 예상됩니다. ( 21.7 %)

성장 기업 발견

기업 분석 및 재무 데이터 현황

데이터	마지막 업데이트(UTC 시간)
기업 분석	2024/12/25 00:35
장 마감 주가	2024/12/24 00:00
수익	2024/09/30
연간 수익	2024/03/31

데이터 소스

기업 분석에 사용된 데이터는 S&P Global Market Intelligence LLC의 데이터입니다. 이 보고서를 생성하기 위해 분석 모델에 사용된 데이터는 다음과 같습니다. 데이터는 정규화되어 있으므로 소스가 제공되기까지 지연이 발생할 수 있습니다.

패키지	데이터	기간	미국 소스 예시 ^*
회사 재무	10년	손익 계산서 현금 흐름표 대차 대조표	SEC 양식 10-K SEC 양식 10-Q
애널리스트 컨센서스 추정치	+3년	재무 예측 애널리스트 목표가	애널리스트 연구 보고서 Blue Matrix
시장 가격	30년	주식 가격 배당금, 분할 및 액션	ICE 시장 데이터 SEC 양식 S-1
소유권	10년	최대 주주 내부자 거래	SEC 양식 4 SEC 양식 13D
관리	10년	리더십 팀 이사회	SEC 양식 10-K SEC 양식 DEF 14A
주요 개발 사항	10년	회사 공지 사항	SEC 양식 8-K

* 미국 증권의 경우, 미국 외 지역의 규제 양식 및 출처가 사용된 예입니다.

명시되지 않는 한 모든 재무 데이터는 1년을 기준으로 하지만 분기별로 업데이트됩니다. 이를 후행 12개월(TTM) 또는 최근 12개월(LTM) 데이터라고 합니다. 여기에서 자세히 알아보세요.

분석 모델 및 눈송이

이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 Github 페이지에서 확인할 수 있으며, 보고서 사용 방법에 대한 가이드와 튜토리얼도 유튜브에서 확인할 수 있습니다.

Simply 월스트리트 분석 모델을 설계하고 구축한 세계적인 수준의 팀에 대해 알아보세요.

산업 및 부문 메트릭

업계 및 섹션 지표는 Simply Wall St에서 6시간마다 계산되며, 자세한 내용은 확인할 수 있습니다.

애널리스트 출처

Apollo Hospitals Enterprise Limited 55 애널리스트 중 29 애널리스트가 보고서의 입력 자료로 사용된 매출 또는 수익 추정치를 제출했습니다. 애널리스트의 제출 자료는 하루 종일 업데이트됩니다.

분석가	교육기관
Prashant Nair	Ambit Capital
Nitin Bhasin	Ambit Capital
null null	Anand Rathi Shares and Stock Brokers Limited

Apollo Hospitals Enterprise 미래 성장

Future 기준 확인 5/6

주요 정보

최근 미래 성장 업데이트

Price target increased by 7.6% to ₹7,848

Here's What Analysts Are Forecasting For Apollo Hospitals Enterprise Limited (NSE:APOLLOHOSP) After Its Second-Quarter Results

The Apollo Hospitals Enterprise Limited (NSE:APOLLOHOSP) First-Quarter Results Are Out And Analysts Have Published New Forecasts

Consensus EPS estimates increase by 16%

Price target increased by 9.7% to ₹6,714

Analysts Are Updating Their Apollo Hospitals Enterprise Limited (NSE:APOLLOHOSP) Estimates After Its Third-Quarter Results

Recent updates

Is Apollo Hospitals Enterprise (NSE:APOLLOHOSP) A Risky Investment?

Price target increased by 7.6% to ₹7,848

Here's What Analysts Are Forecasting For Apollo Hospitals Enterprise Limited (NSE:APOLLOHOSP) After Its Second-Quarter Results

Second quarter 2025 earnings: EPS and revenues exceed analyst expectations

Apollo Hospitals Enterprise Limited to Report Q2, 2025 Results on Nov 06, 2024

Why We Think Apollo Hospitals Enterprise Limited's (NSE:APOLLOHOSP) CEO Compensation Is Not Excessive At All

The Apollo Hospitals Enterprise Limited (NSE:APOLLOHOSP) First-Quarter Results Are Out And Analysts Have Published New Forecasts

New minor risk - Financial position

Upcoming dividend of ₹10.00 per share

Apollo Hospitals Enterprise's (NSE:APOLLOHOSP) Upcoming Dividend Will Be Larger Than Last Year's

Apollo Hospitals Enterprise Limited, Annual General Meeting, Aug 30, 2024

Insufficient new directors

Apollo Hospitals Enterprise Limited to Report Q1, 2025 Results on Aug 13, 2024

Apollo Hospitals Enterprise (NSE:APOLLOHOSP) Is Increasing Its Dividend To ₹10.00

Consensus EPS estimates increase by 16%

Apollo Hospitals Enterprise Limited Recommends Final Dividend for the Fiscal Year 2023-24

Apollo Hospitals Enterprise Limited to Report Q4, 2024 Results on May 30, 2024

Advent International Reportedly Queues Up for A Stake in Apollo 24/7

Apollo Hospitals Enterprise's (NSE:APOLLOHOSP) Returns On Capital Are Heading Higher

Apollo Hospitals Enterprise Limited Announces Term Completion of Vinayak Chatterjee as Independent Director and Reconstitution of Committees

Apollo Hospitals Announces Management Changes

These 4 Measures Indicate That Apollo Hospitals Enterprise (NSE:APOLLOHOSP) Is Using Debt Reasonably Well

Upcoming dividend of ₹6.00 per share at 0.3% yield

Price target increased by 9.7% to ₹6,714

Analysts Are Updating Their Apollo Hospitals Enterprise Limited (NSE:APOLLOHOSP) Estimates After Its Third-Quarter Results

Dividend of ₹6.00 announced

Third quarter 2024 earnings: EPS misses analyst expectations

Apollo Hospitals Enterprise Limited Declares Interim Dividend for the Financial Year Ending 31st March 2024, Payable on or Before 6th March 2024

Apollo Hospitals Enterprise Limited's (NSE:APOLLOHOSP) Share Price Not Quite Adding Up

Apollo Hospitals Enterprise Limited to Report Q3, 2024 Results on Feb 08, 2024

Second quarter 2024 earnings: EPS misses analyst expectations

Apollo Hospitals Enterprise Limited to Report Q2, 2024 Results on Nov 09, 2023

Apollo Hospitals Enterprise Limited Appoints Madhu Sasidhar as Chief Strategy Officer of the Company W.E.F. 1St October, 2023

New minor risk - Financial position

Upcoming dividend of ₹9.00 per share at 0.4% yield

Full year 2023 earnings: EPS misses analyst expectations

Apollo Hospitals Plans Digital Arm Stake Sale

Apollo Hospitals Enterprise Limited, Annual General Meeting, Aug 28, 2023

Full year 2023 earnings: EPS misses analyst expectations

Apollo Hospitals Enterprise Limited to Report Q4, 2023 Results on May 30, 2023

Upcoming dividend of ₹6.00 per share at 0.3% yield

Third quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Apollo Hospitals Enterprise Limited to Report Q3, 2023 Results on Feb 14, 2023

Second quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

First half 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Apollo Hospitals Enterprise Limited to Report Q2, 2023 Results on Nov 10, 2022

Apollo Hospitals Enterprise Limited (NSEI:APOLLOHOSP) agreed to acquire 60% stake in Kerala First Health Services Pvt. Ltd. for INR 263.7 million.

Upcoming dividend of ₹11.75 per share

Full year 2022 earnings: EPS exceeds analyst expectations

Apollo Hospitals Enterprise Limited to Report Q1, 2023 Results on Aug 11, 2022

Apollo Hospitals Enterprise Limited Recommends Dividend for the Financial Year Ended 31st March 2022, payable on or before 6th September 2022

MD & Executive Director recently bought ₹9.5m worth of stock

Adani, Apollo Reportedly Explore Bids for Majority Stake in Metropolis

Full year 2022 earnings: EPS exceeds analyst expectations

Apollo Hospitals Enterprise Limited Recommends Dividend for the Financial Year Ended 31 March 2022

Amazon, Flipkart Reportedly in Talks to Buy Stake in Metropolis Healthcare

Apollo Hospitals Enterprise Limited (NSEI:APOLLOHOSP) acquired Junction Mall for INR 1.7 billion.

Third quarter 2022 earnings: EPS misses analyst expectations

Apollo Hospitals Enterprise Limited to Report Q3, 2022 Results on Feb 11, 2022

MD & Executive Director recently sold ₹3.6b worth of stock

Investor sentiment improved over the past week

Price target increased to ₹5,205

Second quarter 2022 earnings released: EPS ₹17.24 (vs ₹4.33 in 2Q 2021)

Consensus EPS estimates increase to ₹57.32

Investor sentiment improved over the past week

Price target increased to ₹4,231

Full year 2021 earnings released: EPS ₹10.74 (vs ₹32.70 in FY 2020)

수익 및 매출 성장 예측

애널리스트 미래 성장 예측